GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations

First Page		Document Content
Date: 2013-02-24 19:40:20 Organofluorides Pharmacology Integrase inhibitors Tenofovir Emtricitabine Gilead Cobicistat Elvitegravir GS Gilead Sciences Chemistry Organic chemistry		GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations Add to Reading List Source URL: gilead.com Download Document from Source Website File Size: 85,96 KB Share Document on Facebook

	GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations DocID: 1oSag - View Document
	Poster Number Population Pharmacokinetics of Cobicistat in Adult Healthy Subjects and HIV-infected Patients DocID: 1lVQr - View Document
	Poster Number Population Pharmacokinetics of Cobicistat in Adult Healthy Subjects and HIV-infected Patients DocID: 1lKnC - View Document
	0000000000000000002223773 DocID: 1lyWw - View Document
	Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section "MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA." Generic name: efaviren DocID: 1lg5I - View Document